Insider Trading Activity Editas Medicine Inc (NASDAQ:EDIT) – Insider Sold 9,134 shares of Stock

Insider Trading Activity For Editas Medicine Inc (NASDAQ:EDIT)

Katrine Bosley , Insider of Editas Medicine Inc (NASDAQ:EDIT) reportedly Sold 9,134 shares of the company’s stock at an average price of 45 for a total transaction amount of $411,030.00 SEC Form

Insider Trading History For Editas Medicine Inc (NASDAQ:EDIT)

  • On 2/8/2016 James E Flynn, Insider, bought 100,000 with an average share price of $16.00 per share and the total transaction amounting to $1,600,000.00.
  • On 8/23/2016 Alexandra Glucksmann, COO, sold 1,000 with an average share price of $20.00 per share and the total transaction amounting to $20,000.00.
  • On 9/6/2016 Kevin P. Starr, Major Shareholder, sold 5,890 with an average share price of $15.90 per share and the total transaction amounting to $93,651.00.
  • On 9/8/2016 Polaris Venture Management Co., Major Shareholder, sold 500,000 with an average share price of $16.80 per share and the total transaction amounting to $8,400,000.00.
  • On 11/15/2016 Kevin Bitterman, Director, sold 88,900 with an average share price of $16.96 per share and the total transaction amounting to $1,507,744.00.
  • On 11/22/2016 Polaris Venture Management Co., Major Shareholder, sold 12,819 with an average share price of $15.77 per share and the total transaction amounting to $202,155.63.
  • On 11/23/2016 Kevin Bitterman, Director, sold 21,480 with an average share price of $15.71 per share and the total transaction amounting to $337,450.80.
  • Analyst Ratings History For Editas Medicine Inc (NASDAQ:EDIT)

    • On 2/15/2017 Jefferies Group Reiterated Rating Buy with a price target of $35.00
    • On 3/27/2017 Chardan Capital Initiated Coverage of rating Buy to Buy
    • On 7/18/2017 Oppenheimer of rating Market Perform
    • On 8/9/2017 JPMorgan Chase & Co. Set Price Target of rating Hold with a price target of $27.00
    • On 10/6/2017 Morgan Stanley Reiterated Rating Equal Weight with a price target of $27.00 to $28.00
    • On 11/7/2017 Cowen Reiterated Rating Buy
    • On 1/23/2018 SunTrust Banks Upgraded rating Hold to Buy with a price target of $17.00 to $45.00

    Recent Trading Activity for Editas Medicine Inc (NASDAQ:EDIT)
    Shares of Editas Medicine Inc closed the previous trading session at with 40.04999923706055 shares trading hands.

    An ad to help with our costs